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ORIGINAL ARTICLE
Progesterone exerts antidepressant-like effect in a mouse model of maternal
separation stress through mitigation of neuroinflammatory response and
oxidative stress
Ali Nouri , Farzaneh Hashemzadeh, Amin Soltani, Elham Saghaei and Hossein Amini-Khoei
Medical plants Research Center, Basic Health Sciences Institute, Shahrekord University of Medical Sciences, Shahrekord, Iran
ABSTRACT
Context: Experiencing early-life adversity plays a key role in the development of mood disorders in adult-
hood. Experiencing adversities during early life period negatively affects brain development. Sex steroids
such as progesterone affect the brain structure and functions and subsequently affects behaviour.
Objective: We assess the antidepressant-like effect of progesterone in a mouse model of maternal separ-
ation (MS) stress, focussing on its anti-neuroinflammatory and antioxidative effects.
Materials and methods: NMRI mice were treated with progesterone (10, 50, and 100mg/kg, i.p., respect-
ively) for 14days. Valid behavioural tests including forced swimming test (FST), splash test and open field
test (OFT) were used. Quantitative reverse transcription-PCR (qRT-PCR) was used for evaluation of genetic
expression in the hippocampus. Antioxidant capacity was assessed by the FRAP method and the level of
malondialdehide by TBA.
Results: MS provoked depressive-like behaviour in mice. Treatment of MS mice with progesterone
increased the grooming activity time in the splash test and decreased the immobility time in the FST. In
addition, progesterone decreased the expression of inflammatory genes related to neuroinflammation (IL-
1b, TNF-a, TLR4 and NLRP3) as well as increased the antioxidant capacity and decreased the lipid peroxi-
dation (MDA) in the hippocampus.
Discussion and Conclusion: Administration of progesterone significantly mitigated the negative effects of
MS on behaviours relevant to depressive-like behaviour as well as attenuated neuro-immune response and
oxidative stress in the hippocampus of MS mice. In this context, we conclude that progesterone, at least
partially, via attenuation of oxidative stress and neuroinflammation, exerts antidepressant-like effects.
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Introduction
Depression is one of the most prevalent psychiatric disorders
and the main cause of disability in the twenty-first century
(€Ust€un 2001; Murray et al. 2012). It is characterised by sadness,
loss of interest or pleasure, decreased energy or feelings of tired-
ness, feelings of low self-worth, disturbed sleep or appetite, and
poor concentration (Chen et al. 2015). Experiencing early-life
adversity plays a key role in the development of the mood disor-
ders in humans and rodents (Lupien et al. 2009; Rao et al. 2010).
The early postnatal period is accompanied by significant mat-
uration of the nervous system. Experiencing stressful conditions
during this period results in the majority of neurobehavioral,
neurochemical and immune-inflammatory abnormalities in later
life (Rice and Barone Jr. 2000). In this regard, maternal separ-
ation (MS) is well-known as a valid animal model which leads to
behavioural and developmental disturbances in adulthood (Solas
et al. 2010; Martisova et al. 2012). Although various studies for
introduction of new agents have been performed, there are no
fully satisfactory treatments yet available for treatment of depres-
sion (Kupfer et al. 2012).
Clinical studies have shown that children who suffer adverse
experiences have a greater risk for developing future psychiatric
illnesses, including depression, anxiety disorders, attention def-
icit/hyperactivity disorders, and cognitive deficits (Heim and
Nemeroff 2001). Although the neural circuits and biochemical
signalling that account for the behavioural changes subsequent to
this phenomenon are largely unknown, studies have shown that
the development of the prefrontal cortex, the hippocampus and
the amygdala can be modulated by emotional experiences during
early postnatal life (Carlyle et al. 2012).
It has been determined that sex steroids such as progesterone
affects the brains structure and functioning and subsequently
affects behaviour (Hines 1982). Gonadotropins and sex steroids
have been shown to have direct influence on regulating of the
brain structure and function. In this regard, it has been sug-
gested that progesterone exerts neuroprotective effects in various
experimental neurological disorders (Roof et al. 1994, 1997;
Shear et al. 2002; He et al. 2004; Stein and Wright 2010).
Furthermore, progesterone and progesterone-derived metabolites
play important roles in the pathogenesis of psychological diseases
(Wirth 2011).
It has been shown that progesterone is metabolised to the
allopregnanolone, which can affect neuron functions and behav-
iour. In this context, there is evidence that progesterone and
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allopregnanolone are not only produced by peripheral glands
(e.g., ovary, adrenal gland) but are also produced in the brain
(Wirth 2011; Frye et al. 2014). Progesterone has potent anti-
inflammatory and antioxidant properties (Roof et al. 1997; He
et al. 2004; Stein and Wright 2010). Previous studies have dem-
onstrated that experiencing early life stress reduces the effective-
ness of the progesterone and its metabolites in the brain (Lai
and Huang 2011; Brunton 2015).
Ample evidence has indicated that neuro-inflammation is a
contributing factor in the pathophysiology of psychiatric disor-
ders such as depression (Maes et al. 2009; Jones and Thomsen
2013). Inflammatory cytokines are involved in neuronal dysfunc-
tions as well as neuro-immune response in psychiatric disorders
(Maes 1995; Dowlati et al. 2010). Toll like receptors (TLRs),
tumour necrosis factor alpha (TNF-a), interleukin 1-beta (IL-1b)
and inducible nitric oxide synthase (iNOS) are parts of compo-
nents of the innate immunity in mood disorders such as depres-
sion (Andreasson et al. 2016).
It is well-known that activation of the NOD-, LRR- and pyrin
domain-containing protein 3 (NLRP3) inflammasome leads to
production of inflammatory cytokines in the CNS. In this con-
text, it has been suggested that NLRP3 could be considered a
potential therapeutic target for affective disorders (Haneklaus
et al. 2013; Xu et al. 2016).
In the current study we assess the antidepressant-like property
of progesterone in a mouse model of MS stress, considering its
anti-neuroinflammatory and antioxidative effects.
Materials and methods
Animals
The protocol for this project was approved by the ethics commit-
tee of the Shahrekord University of Medical Sciences and all
experiments were performed according to the institutional guide-
lines for animal care and use. Forty-eight NMRI mice were
housed in a facility with 12 h light/dark cycle, temperature
22 ± 1 C and were given food and water ad libitum.
Maternal separation paradigm
Pregnant NMRI mice (Pasteur Institute, Tehran, Iran) were used
in this study. The birth date was considered as postnatal day 0
(PND 0). After birth, at PND 2 the offspring were subjected to
the MS paradigm. For this purpose, pups were separated from
their mothers for 3 h daily during PND 2–14, beginning at 10:00
a.m., and returned to their mothers after the 3 h separation
period (Amini-Khoei et al. 2017, 2019).
At the end of PND 14, pups were returned to their mother’s
cages and remained undisturbed until PND 25. On PND 25,
male mice were weaned and divided into six experimental groups
(four mice per cage) with treatment beginning from PND 44
until experiment day (PND 58–60). We did not touch the con-
trol animals and they were left undisturbed and were weaned on
PND 25 and grouped (four mice per cage) until PND 58–60 for
experiments. All tests were performed between 9:00 a.m. and
1:00 p.m. All experimental groups involved eight mice, and we
tried to minimise the use of animals and to improve their
well-being.
Study design
Maternally separated and control mice were randomly divided
into six experimental groups as follows (n¼ 8/group). Group 1:
control group treated with normal saline for 14 days. Group 2:
MS mice received normal saline for 14 days. Groups 3, 4 and 5:
MS mice treated with progesterone (10, 50, and 100mg/kg, i.p.,
respectively) for 14 days. Group 6: MS mice treated with fluoxet-
ine (30mg/kg, i.p.) for 14 days. All behavioural experiments were
performed in adult mice (PND 58–60). At the end of our study,
the animals were sacrificed (decapitated) and the hippocampi
were separated on an ice-cold surface and directly snapped fro-
zen in liquid nitrogen and kept in the freezer at 70 C until the
start of molecular assays. The doses and times of drug adminis-
trations were selected according to our pilot study as well as pre-
vious studies (Martınez-Mota et al. 1999; Molina-Hernandez and
Tellez-Alcantara 2001; Taniguti et al. 2019). Duration of treat-
ments was from PND 44 (early adulthood) until PND 58–60
(adulthood), for 14 constant days.
Forced swimming test (FST)
FST is a valid test for evaluation of new antidepressants in which
elevated immobility time is related to disappointment behaviour
demonstrating the depressive-like behaviour in animals (Porsolt
et al. 1977). Mice were individually forced to swim in a cylin-
drical glass tank (diameter: 10 cm, height: 25 cm) containing
19 cm of water (23 ± 1 C) and passive behaviour (immobility
time) was measured for 6min and animal behaviour was
recorded at last 4min of test. Immobility was defined as a period
during which the animal floated in the water, making only those
movements necessary to keep its head above the water (Amiri
et al. 2016).
Open-field test (OFT)
We used OFT to evaluate the effects of MS, FLX treatment and
progesterone treatment and to validate the results of FSD test
(Amiri et al. 2015; Sonei et al. 2017). The open-field apparatus
was made of white opaque Plexiglas (50 cm  50 cm  30 cm),
which was dimly illuminated. Each mouse was placed into the
central zone of the open-field and its behaviours were recorded
by camera for 5min and evaluated by Ethovision software ver-
sion 8 (Noldus, Netherlands). The surface of the apparatus was
cleaned with 70% ethanol after testing each animal. The distance
moved (horizontal activity) and the number of rearings (vertical
activity) was measured in OFT.
Splash test
In order to evaluate motivational deficits and self-care difficulties
in rodents we used the splash test (Haj-Mirzaian et al. 2016;
Haj-Mirzaian, Amini-Khoei, et al. 2017). To do this, grooming
behaviour, which can be considered an indirect measure of palat-
able solution intake, was measured. A 10% sucrose solution was
squirted on the dorsal coat of animals in their home cage. First
grooming latency and time spent grooming were recorded for a
period of 5min.
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Quantitative reverse transcription-PCR (qRT-PCR) analysis
for hippocampus inflammatory genes
Trizol (Invitrogen; Life Technologies, Grand Island, NY, USA)
was used to isolate hippocampi RNA as described by the manu-
facturer’s protocol. The samples were verified to be free of con-
taminating DNA, as no signal originating from genomic DNA
was observed among the no reverse transcription controls.
Isolated RNA was checked for purity by ensuring that the OD
260/280 ratio was greater than 1.8. For qRT-PCR, SYBR green
detection was used according to the manufacturer’s protocol
(Bio-Rad QPCR kit; Hercules, CA, USA). A Rotor-Gene Q real
time thermocycler was used to collect the data. Thermal cycling
conditions included an initial activation step for 30 s at 95 C
after 45 cycles as well as a denaturation step for 5 s at 95 C and
a combined annealing/extension step for 20 s at 60 C. Melting
curve analysis was performed to certify whether all primers
yielded a single PCR product. All PCR primer pairs used gener-
ated amplicons between 90 and 110 base pairs (Table 1). Histone
H2A variant, H2afz, was used as a house-keeping gene (normal-
izer) and alterations in expression of each target mRNA in com-
parison with H2afz was measured based on the 2DDCt relative
expression formula. Studies in mice have shown that this par-
ticular histone is required for development.
Ferric reducing/antioxidant power (FRAP) assay
Ferric reducing/antioxidant power was determined based on
method described in previous studies (Heidarian and Soofiniya
2011). Briefly, plasma was mixed with FRAP reagent (composed
of: 25mL acetate buffer, 2.5mL TPTZ solution and 2.5mL
FeCl3) then incubated at 37 C for 10min and optical density of
blue colour was measured at 593 nm. FeSO4 was used as a stand-
ard of FRAP assay at a concentration range between 100 and
1000 lM. The results are reported as lmol/mg.
Determination of lipid peroxidation (LPO)
MDA content in the rat hippocampus was determined by the
TBA reactive substance test as described previously (Heidarian
and Soofiniya 2011). Briefly, plasma or supernatant was mixed
with sodium dodecyl sulphate (8.1%) and TBA/buffer (composed
of 0.53% thiobarbituric acid in 20% acetic acid as adjusted to pH
3.5 with NaOH), then incubated at 95 C for 60min. The reac-
tion was stopped by placing tubes in ice followed by centrifuga-
tion at 4000 rpm for 10min. The optical density of the pink
colour was measured at 532 nm.1, 1, 3, 3-tetraethoxypropane was
used as a standard of MDA assay. The measurements were done
in duplicate and the results were expressed in lmol/mg.
Results
Progesterone attenuates the depressive-like behaviours
of MS
We assessed the effect of MS on depressive-like behaviours,
including behavioural despair, motivational difficulty using the
FST and splash test, respectively (Figure 1). In the FST, MS mice
have an elevation in the immobility time when compared to con-
trol animals (p< 0.001). Results indicate that MS led to a
remarkable decrease in grooming activity time in the splash test
in comparison with control group (p< 0.001). In the OFT, MS
remarkably elevated the total distance moved (horizontal activity)
(p< 0.05) and number of rearings (vertical activity) (p< 0.05)
compared to the control group.
The effects of various doses of progesterone (10, 50 and
100mg/kg) was evaluated on depressive-like behaviours
(Figure 1). One-way ANOVA analysis demonstrated that treat-
ment with progesterone (10, 50mg/kg) created significant
changes in depressive-like behaviours in MS mice in compared
to the saline-treated MS mice in the FST (p< 0.01) and splash
test (p< 0.01). However, dose of 100mg/kg of progesterone had
no effect in the aforesaid behavioural tests in MS mice. In the
OFT, Tukey’s post hoc analysis showed that administration of
progesterone (10mg/kg) to MS mice significantly decreased the
vertical activity in comparison with the saline-treated MS mice
(p< 0.05). However, MS mice did not significantly respond to
progesterone (10, 50 and 100mg/kg) in the horizontal activity
in OFT.
Progesterone decreases the MDA content of the
hippocampus
Lipid peroxidation measurement was made in hippocampus
because this tissue was directly involved on depression, so any
damage in hippocampus should be related to depressive signs.
Figure 2 indicates that MS led to a remarkable elevation in MDA
level (p< 0.001) in compared to the control group. Treatment
with progesterone at doses of 50 and 100mg/kg in MS mice
leads to significant reduction (p< 0.001 and p< 0.05, respect-
ively) in MDA content in compared to the saline-treated MS
mice. However, treatment with progesterone at dose of 10mg/kg
in MS mice could not exert significant change in MDA content
in compared to the saline-treated MS mice. Fluoxetine also sig-
nificantly decreased (p< 0.01) the hippocampal MDA level in
compared to the saline-treated MS mice.
Progesterone reduses the hippocampal total
antioxidant capacity
Figure 3 shows that MS caused a significant reduction in the
hippocampus antioxidant capacity in comparison with the con-
trol group (p< 0.001). However, treatment with progesterone at
doses of 50 and 100mg/kg in MS mice significantly elevated the
hippocampus antioxidant capacity in compared to the saline-
treated MS mice (p< 0.001 and p< 0.01, respectively). However,
MS mice did not significantly respond to treatment with proges-
terone at dose of 10mg/kg. We showed that fluoxetine signifi-
cantly increased the hippocampus antioxidant capacity in
compared to the saline-treated MS mice (p< 0.01).
Table 1. Primer Sequences.
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Progesterone decreased the expression of inflammatory
genes in the hippocampus
Figure 4 shows the expression of genes related to neuro-immune
responses in the hippocampus. One-way ANOVA analysis
showed that there were significant differences between experi-
mental groups. Tukey’s post hoc analysis demonstrated that
expression of the IL-1b (p< 0.001), TNF-a (p< 0.001), iNOS
(p< 0.05), TLR4 (p< 0.001) and NLRP3 (p< 0.001) significantly
increased in the hippocampus of MS mice in comparison with
the control mice. Results showed that treatment with progester-
one at dose of 50mg/kg significantly reduced expression of
IL-1b (p< 0.01), TNF-a (p< 0.01), NLRP3 (p< 0.05) in the
hippocampus in comparison with the saline-received counterpart.
Also, treatment with progesterone at dose of 100mg/kg
significantly decreased the expression of IL-1b (p< 0.001), TNF-
a (p< 0.01), TLR4 (p< 0.05) and NLRP3 (p< 0.001) in the
hippocampus when compared with the saline-treated counter-
parts. However, treatment with progesterone at dose of 10mg/kg
did not lead to significant changes in the expression of inflam-
matory genes in MS mice.
Discussion
Our results demonstrated that MS stress provokes depressive-like
behaviours in adult male mice in behavioural tests including
FST, OFT and the splash test. We observed that progesterone
provokes antidepressant-like effects in MS mice. The expression
of inflammatory genes related to neuro-immune response
increased in the hippocampus of MS mice. Also, our results indi-
cated that MS increased the MDA level and decreased the
Figure 1. Effects of MS and progesterone on depressive-like behaviours in male mice: FST (A), splash test (B) and OFT (horizontal activity: C and vertical activity: D).
Values are presented as mean± S.E.M from eight animals and were analysed using one-way ANOVA followed by Tukey post hoc test. p< 0.05 and p< 0.001
compared to the control group, #p< 0.05, ##p< 0.01 and ###p< 0.001 compared with the salinereceived MS mice.
Figure 2. Effects of MS and progestrone on MDA content in the hippocampus.
Values are presented as mean±S.E.M from six samples and were analysed using
one-way ANOVA followed by Tukey post hoc test. p< 0.001 compared to the
control group, #p< 0.05, ##p< 0.01 and ###p< 0.001 compared with the saline-
treated MS mice.
Figure 3. Effects of MS and progestrone on total antioxidant capacity in the
hippocampus. Values are presented as mean± S.E.M from six samples and were
analysed using one-way ANOVA followed by Tukey post hoc test. p< 0.001
compared to the control group, ##p< 0.01 and ###p< 0.001 compared with the
saline-received MS mice.
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antioxidant capacity in the hippocampus of MS mice. Moreover,
we found that progesterone attenuates the neuro-immune
response, decreases the MDA level and increases the antioxidant
capacity of the hippocampus of MS mice.
Ample evidence indicates that experiencing stressful events
during early stages of life have profound and long-lasting effects
on brain development and behaviour (Lupien et al. 2009). Our
results are in line with previous studies that reported MS is able
to provoke depressive-like behaviours in mice (Vetulani 2013;
Marco et al. 2015). We showed that MS mice have increased
immobility time in the FST compared with the control animals.
An increase in immobility time in the FST reflects behavioural
despair in mice (Cryan and Holmes 2005). Our findings showed
that treatment with progesterone significantly reduced the immo-
bility time in the FST, indicating that progesterone exerted anti-
depressant-like effects.
The splash test is an accepted method evaluating the self-care
difficulties and motivation in mice (Marrocco et al. 2014). Our
findings revealed that MS mice have decreased grooming activity
time compared to control mice. Treatment with progesterone is
able to increase the grooming activity time in the splash test.
These results suggest that progesterone exerts antidepressant-like
effects in MS mice.
In this study, OFT was applied immediately before the FST to
evaluate the ambulatory behaviour of the mice and also confirm
that variations which occur in motor activity did not affect the
duration of immobility in the FST (Kaster et al. 2005). In the
OFT, MS mice showed an increase in locomotion in both verti-
cal and horizontal activities. In the case of OFT, it should be
noted that there is an inconsistency in the literature regarding
OFT results following the MS paradigm. In this regard, previous
studies reported that MS decreases locomotion (Millstein and
Holmes 2007), increases locomotion (Cannizzaro et al. 2006) or
does not change ambulation in the OFT (Shalev and
Kafkafi 2002).
To investigate the possible mechanism of progesterone, we
measured lipid peroxidation (LPO) and the anti-oxidant capacity
of the hippocampus. We examined the total antioxidant activity
using FRAP as an indicator of the strength of non-enzymatic
antioxidants and LPO using MDA content as a marker of LPO
Figure 4. Effects of MS and progestrone on the gene expression of immune-inflammatory genes (Il-1b, TNFa, iNOS, TLR4 and NLRP-3) in the hippocampus. Data are
expressed as the mean± S.E.M from six samples and were analysed by one-way ANOVA. p< 0.05 and p< 0.001 compared to the control group, #p< 0.05,
##p< 0.01 and ###p< 0.001 compared with the saline-received MS mice.
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(Thirunavukkarasu et al. 2012; Nouri et al. 2017). In our study,
the levels of MDA were significantly increased and the content
of antioxidant capacity markedly decreased in MS mice, which
indicates lipid proxidation and oxidative stress in the hippocam-
pus which are in agreement with prior studies (Arabameri et al.
2017; Menezes et al. 2017). Treatment with progesterone not
only increased antioxidant capacity, but also decreased the MDA
level in the hippocampus of MS mice. These protective effects of
progesterone might be due to its antioxidant and free radical
scavenging properties. Therefore, it seems that progesterone can
reduce the oxidative stress caused by MS.
It has been reported that stress induces immunomodulatory
effects through modifications in the HPA axis and the sympa-
thetic nervous system (Miller and Raison 2016). Recent studies
have emphasised the role of inflammatory pathways in the
pathophysiology of depression. Involvement of TLRs and subse-
quent activation of an inflammatory response in behavioural
abnormalities has recently been reported in animal models of
chronic stress (Pascual et al. 2015; Sadeghi et al. 2016).
Previous studies demonstrated the central role for NLRP3
inflammasome in stress-induced depressive-like behaviours.
Stress had long been considered as an important contributing
factor in the pathology of depression. Activation of TLR4 and
NLRP3 leads to overproduction of inflammatory cytokines
(Kupfer et al. 2012; Pan et al. 2014). Our data showed that MS
caused an increase in the genes expression of TLR4, TNF-a, IL-
1b, iNOS and NLRP3 in the hippocampus tissue. This result is
consistent with recent studies that have demonstrated MS-
induced depressive- like behaviours are associated with the acti-
vation of inflammatory responses in the hippocampus (Roque
et al. 2016; Sadeghi et al. 2016; Haj-Mirzaian, Amiri, et al. 2017).
In this research, we found that treatment with progesterone suc-
ceeded to attenuate the increased expression of TLR4, TNF-a,
and IL-1b in the hippocampus of mice exposed to MS paradigm.
Our results suggested that progesterone has anti-inflammatory
effects through the downregulation of TLR4, TNF-a, IL-1b,
and NLRP3.
Clinical and preclinical studies have demonstrated that pro-
gesterone exerted antidepressant (-like) effect (Gordon et al.
2018; Hu et al. 2019). As evidence for their importance to the
brain, progesterone and allopregnanolone are produced not only
by peripheral glands (e.g., ovary; adrenal gland), but also by the
brain itself (Wirth 2011). There are studies demonstrating that
stress decreases the level of steroids such as progesterone in the
CNS (Weisz et al. 1982; Barbaccia et al. 2001). The impact of
early-life stress on the brain’s capability to produce neurosteroids
such as progesterone has been studied previously. In this regard,
evidence demonstrated that experiencing early life stress could
reduce the level of neurostroids in the brain (Brunton 2015;
Santos et al. 2018).
Several studies have demonstrated that progesterone could
stimulate neurogenesis in the hippocampus (Novais et al. 2018;
Montes et al. 2019). So, considering involvement of the hippo-
campus in the pathophysiology of depression, understanding of
the impact of early-life stress on brain neurosteroid systems
could help to identify new targets for developing treatments for
stress-related psychopathies like depression. In this study we
found that facing early life stress is linked with depressive-like
behaviour in adult male mice. Interestingly, we observed that
administration of the progesterone attenuated the negative effects
of maternal separation stress on behaviours of adult male mice.
Our findings suggested that MS can, at least, disturb the neur-
onic circuits in the brain and disturb the function and/or
production of steroids such as progesterone in the CNS. This
indicates that further studies on this subject should be conducted
to clarify the effect of MS on the steroidogenesis.
Conclusion
We concluded that progesterone through attenuation of neuro-
inflammatory response and mitigation of oxidative stress,
partially at least, exerts antidepressant-like effects in maternally
separated mice.
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